Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0COBJL
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
DS001
|
|||||
| Synonyms |
DS 001; DS-001
Click to Show/Hide
|
|||||
| Organization |
Tashi Pharmaceutical (Guangdong) Co., Ltd.; Shanghai Institute of Materia Medica Chinese Academy of Sciences
|
|||||
| Drug Status |
Phase 1
|
|||||
| Indication |
In total 1 Indication(s)
Solid tumors [ICD11:2A00-2A0Z|2B50-2F9Z]
Phase 1
|
|||||
| Antibody Name |
Undisclosed
|
Antigen Name |
Undisclosed
|
|||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
VK linker technology
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.